Ambeed.cn

首页 / / / / Doxycycline hyclate/盐酸强力霉素

Doxycycline hyclate/盐酸强力霉素 {[allProObj[0].p_purity_real_show]}

货号:A148893 同义名: 多西环素盐酸盐半乙醇半水合物 / WC2031; Doxycycline hydrochloride hemiethanolate hemihydrate

Doxycycline hyclate是一种口服活性、广谱抗生素和金属蛋白酶(MMP)抑制剂。它表现出抗菌和抗癌细胞增殖活性。

Doxycycline hyclate/盐酸强力霉素 化学结构 CAS号:24390-14-5
Doxycycline hyclate/盐酸强力霉素 化学结构
CAS号:24390-14-5
Doxycycline hyclate/盐酸强力霉素 3D分子结构
CAS号:24390-14-5
Doxycycline hyclate/盐酸强力霉素 化学结构 CAS号:24390-14-5
Doxycycline hyclate/盐酸强力霉素 3D分子结构 CAS号:24390-14-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Doxycycline hyclate/盐酸强力霉素 纯度/质量文件 产品仅供科研

货号:A148893 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Doxycycline hyclate/盐酸强力霉素 生物活性

描述 Doxycycline hyclate is a common broad-spectrum antibiotic. It is also an inhibitor of MMP-8 (nuclear collagenase; IC50 = 30 μM). It also has a certain inhibitory effect on MMP-1 (collagenase-1, IC50 = 300 μM). Its adequate oral absorption and extended half-life, which allows fewer daily doses. Doxycycline hyclate is considered the tetracycline of choice in patients with poor renal function due to its limited clearance by kidneys. It is active against protozoa and can be administered in combination with quinine in the management of chloroquine resistant plasmodium falciparum infection[3].

Doxycycline hyclate/盐酸强力霉素 细胞实验

Cell Line
Concentration Treated Time Description References
HeLa cells 5 ng/ml Induce the expression of hSSB1-WT or hSSB1-DM Signal Transduct Target Ther. 2020 Jun 24;5(1):80.
H1 cells 1 μM 2 or 3 days To assess the function of SMARCB1 in steady state hESCs, qPCR and western blot results showed strong downregulation of SMARCB1 at the transcript and protein levels Elife. 2019 Apr 29;8:e45672.
A375VR4 1 µg/mL 5–6 days To induce shRNA expression for studying the effects of MTH1 knockdown. Cell Death Differ. 2020 Jul;27(7):2081-2098.
human fibroblasts 100 ng/mL 24 h To investigate the effect of Doxycycline-induced myr-Akt expression on HCMV replication, results showed that myr-Akt expression caused a roughly 10-fold decrease in viral replication. mBio. 2022 Aug 30;13(4):e0104222.
HMLE-Twist-ER cells 1–2 μg/mL 15 days Induced LRIG1 expression to limit the expression of EMT markers. Results showed that LRIG1 expression blunted the expression of Fibronectin, Slug, and CD44, indicating that LRIG1 restricts the full expression of EMT markers. Oncogene. 2016 Jun 2;35(22):2932-47.

Doxycycline hyclate/盐酸强力霉素 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice H1299 xenograft model Oral 625 mg/kg Daily for 4 weeks To investigate the effect of SAT1 overexpression on tumor growth, results showed that SAT1 induction significantly suppressed xenograft tumor growth. Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6806-E6812
Nude mice HCT116 xenograft model Intraperitoneal injection 5 mg/kg Every 2 days for 10 days Evaluate the effect of combined treatment of 2-D08 and etoposide on tumor growth Signal Transduct Target Ther. 2020 Jun 24;5(1):80.
Mice TGFα-induced pulmonary fibrosis model Oral 62.5 mg/kg 6 weeks Induced overexpression of TGFα by feeding mice with doxycycline-containing chow to establish a pulmonary fibrosis model. EMBO Mol Med. 2020 Sep 7;12(9):e12131
Mice Cutaneous squamous cell carcinoma (SCC) model Oral 200mg Continuous administration To induce RNAi-mediated knockdown of the SOX2 gene to study its role in cutaneous squamous cell carcinoma growth. Results showed that SOX2 knockdown significantly reduced tumor growth. Nat Commun. 2014 Jul 31;5:4511
Mice ATG5i mouse model Dietary administration 200 ppm 6 weeks To evaluate the effects of systemic Atg5 knockdown, ATG5i mice exhibited many phenotypes similar to tissue-specific knockout models, such as hepatomegaly, reduced adipose tissue, and pancreatic degeneration Autophagy. 2018;14(7):1256-1266

Doxycycline hyclate/盐酸强力霉素 参考文献

[1]Almazin SM, Dziak R, et al. The effect of doxycycline hyclate, chlorhexidine gluconate, and minocycline hydrochloride on osteoblastic proliferation and differentiation in vitro. J Periodontol. 2009 Jun;80(6):999-1005.

[2]Breitschwerdt EB, Hegarty BC, Hancock SI. Doxycycline hyclate treatment of experimental canine ehrlichiosis followed by challenge inoculation with two Ehrlichia canis strains. Antimicrob Agents Chemother. 1998 Feb;42(2):362-8.

[3]Kogawa AC, Zoppi A, Quevedo MA, Nunes Salgado HR, Longhi MR. Increasing doxycycline hyclate photostability by complexation with β-cyclodextrin. AAPS PharmSciTech. 2014;15(5):1209-1217.

Doxycycline hyclate/盐酸强力霉素 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.97mL

0.19mL

0.10mL

4.87mL

0.97mL

0.49mL

9.75mL

1.95mL

0.97mL

Doxycycline hyclate/盐酸强力霉素 技术信息

CAS号24390-14-5
分子式C46H58Cl2N4O18
分子量 1025.87
SMILES Code O=C(C1=C(O)[C@@H](N(C)C)[C@@]([C@@H](O)[C@@]2([H])C(C(C3=C(O)C=CC=C3[C@@H]2C)=O)=C4O)([H])[C@@]4(O)C1=O)N.O=C(C5=C(O)[C@@H](N(C)C)[C@@]([C@@H](O)[C@@]6([H])C(C(C7=C(O)C=CC=C7[C@@H]6C)=O)=C8O)([H])[C@@]8(O)C5=O)N.CCO.[H]Cl.[H]Cl.[H]O[H]
MDL No. MFCD07357237
别名 多西环素盐酸盐半乙醇半水合物 ;WC2031; Doxycycline hydrochloride hemiethanolate hemihydrate; Doxycycline (hyclate)
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Keep in dark place, sealed in dry, room temperature

溶解方案

DMSO: 200 mg/mL(194.96 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 120 mg/mL(116.97 mM),配合低频超声助溶

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。